Bausch Health Companies (BHC) Capital Expenditures (2009 - 2026)

Bausch Health Companies has disclosed Capital Expenditures across 18 years of filings, most recently posting $77.0 million for Q2 2026.

• In Q2 2026, Capital Expenditures fell 22.22% year-over-year to $77.0 million; the TTM figure through Jun 2026 stood at $369.0 million (down 5.63% YoY), while the FY2025 annual figure was $397.0 million, up 17.8% from the prior year.
• Capital Expenditures came in at $77.0 million for Q2 2026 at Bausch Health Companies, down from $109.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $115.0 million in Q1 2025 to a low of $28.0 million in Q2 2023.
• Average Capital Expenditures over 5 years is $75.2 million, with a median of $77.5 million recorded in 2024.
• Year-over-year, Capital Expenditures sank 46.15% in 2023 and soared 178.57% in 2024.
• Over 5 years, Capital Expenditures stood at $66.0 million in 2022, then jumped by 48.48% to $98.0 million in 2023, then rose by 8.16% to $106.0 million in 2024, then decreased by 13.21% to $92.0 million in 2025, then retreated by 16.3% to $77.0 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $77.0 million in Q2 2026, $109.0 million in Q1 2026, and $92.0 million in Q4 2025.